ABOUT US
Making medical care more accurate and understandable with digital twins.
MEDICAL IP leads a paradigm shift in healthcare with innovative technologies.
Built on digital twin, AI and applied 3D technologies, we develop medical imaging analysis technologies that deliver solutions benefiting both patients and clinicians. MEDICAL IP is shaping a new future for healthcare with better medical experiences.
Core Values
LIFE
Technology that saves lives and helps with medical care is paramount.
INNOVATION
We continuously research and develop new and innovative technologies that the medical field and world want.
TRUST
We focus all of our abilities to develop accurate and precise technologies and products that medical staff and patients can trust.
EQUALITY
We welcome and respect all opinions. We value the mutual growth of customers and employees.
Partners & Recognition
7 consecutive years ‘Sample Vendor’
Inception Partner
‘1st Spin-off Start-up’Exclusively Partnered with
Vision
Empowering Medicine,Saving Lives
Mission
- Research technology that leads innovation
- Solve problems that arise in the medical field
- Develop medical solutions that save lives
History
Milestones since our founding as the first spin-off of Seoul National University Hospital.
11 milestones
- 09
- Commenced supply of cardiovascular imaging analysis software DeepCatch X to Yangsan Pusan National University Hospital
- Received the KAIST President's Award at STARTUP NATION KOREA 2025
- 07
- Commenced supply of cardiovascular imaging analysis software DeepCatch X to 17 branches of the Korea Association of Health Promotion (KAHP)
- 06
- Liver cancer occurrence prediction solution DeepFore selected as 'Selection of the Month' in 'From the Editor’s Desk' of the Journal of Hepatology
- Liver cancer occurrence prediction solution DeepFore featured on the cover of the June issue of the Journal of Hepatology
- 05
- Liver cancer occurrence prediction solution DeepFore received MFDS approval (Class III medical device)
- Liver cancer occurrence prediction solution DeepFore published in the Journal of Hepatology, the top journal in the liver field (IF: 33.0)
- 04
- Medical imaging analysis software MEDIP PRO obtained NMPA certification in China (First among domestic AI companies)
- Medical imaging analysis software DeepCatch supplied to PUMC Hospital in China (First among domestic digital healthcare companies)
- 03
- Liver cancer recurrence prediction solution DeepFore Recur received MFDS approval (Class III medical device, first in the liver cancer field)
- 01
- Commenced supply of AI body composition analysis software DeepCatch to Yangsan Pusan National University Hospital
Testimonials
In terms of developing innovative educational content, MEDICAL IP's products offered the most effective solution.
Hyung-Jin Choi, M.D., Ph.D.Seoul National University